Phân tích chi phí điều trị ngoại trú tại Bệnh viện Lê Văn Thịnh giai đoạn 2018–2023

The management of healthcare resources, particularly concerning "outpatient treatment costs", is a critical challenge for hospitals, especially those navigating self-financing models. This study addresses the pressing need for comprehensive data on healthcare expenditures for "health-insured outpatients" at "Le Van Thinh Hospital" (LVTH) during the 2018-2023 period. Understanding these "direct medical costs" is vital for informed decision-making in policy planning, budgeting, and efficient resource allocation, particularly given Vietnam's aging population and the rising prevalence of non-communicable diseases. This research aims to provide a robust analytical framework to support strategic management and enhance healthcare service quality at LVTH.

Hospital administrators, healthcare policymakers, public health researchers, and medical professionals involved in healthcare finance and resource management in Vietnam.

This study provides a detailed analysis of "outpatient treatment costs" incurred by "health-insured outpatients" at "Le Van Thinh Hospital" (LVTH) between 2018 and 2023. Employing a retrospective cross-sectional design, researchers meticulously extracted and processed "direct medical costs" data from the hospital's management software, utilizing Microsoft Excel for analysis. The findings reveal a significant volume of 2,611,655 "outpatient" visits, with a notable proportion of elderly patients (38.8% aged 60+) and females (58.6%). The majority (72.2%) of patients had 80% "health insurance" coverage. The highest "treatment costs" were attributed to diseases of the circulatory system (33.7%), followed by endocrine, nutritional, and metabolic diseases (16.6%), and respiratory system diseases (9.3%), categorized using "ICD-10". A substantial 827.958 billion VND was spent on medication costs for "health-insured" individuals, with the circulatory and endocrine/metabolic systems accounting for the largest shares. The research underscores the significant impact of the COVID-19 pandemic and economic fluctuations on medication expenditure trends. These insights offer a scientific foundation for LVTH's budgeting and human resource allocation, particularly for departments managing high-cost, non-communicable diseases. Furthermore, the results serve as valuable reference information for similar hospitals in policy formulation and resource management, especially in the context of an evolving demographic landscape marked by an aging population and the increasing burden of non-communicable diseases.